MOHAMAD F ATASSI

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease CHICAGO, IL NPI 1073508172

General Payments — all program years on this page

$1,341.31

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 67
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $409.11 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $409.1120

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $180.3112
2019 $372.9615
2020 $75.875
2021 $24.672
2022 $30.782
2023 $247.6111
2024 $409.1120

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086746629 Novartis Pharmaceuticals Corporation $33.06 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086746645 Novartis Pharmaceuticals Corporation $15.32 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096789316 Novo Nordisk Inc $21.59 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096888312 Novo Nordisk Inc $23.75 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097499758 Novo Nordisk Inc $22.84 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101538891 E.R. Squibb & Sons, L.L.C. $22.11 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101538954 E.R. Squibb & Sons, L.L.C. $22.50 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104302092 AstraZeneca Pharmaceuticals LP $14.05 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104675617 AstraZeneca Pharmaceuticals LP $15.29 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105743478 AstraZeneca Pharmaceuticals LP $18.69 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115430976 Amgen Inc. $15.30 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117861259 Boehringer Ingelheim Pharmaceuticals, Inc. $18.51 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117861261 Boehringer Ingelheim Pharmaceuticals, Inc. $19.79 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117861263 Boehringer Ingelheim Pharmaceuticals, Inc. $20.98 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117861265 Boehringer Ingelheim Pharmaceuticals, Inc. $23.54 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117861267 Boehringer Ingelheim Pharmaceuticals, Inc. $25.32 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117861269 Boehringer Ingelheim Pharmaceuticals, Inc. $30.02 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1129426574 Esperion Therapeutics, Inc. $14.64 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1129426576 Esperion Therapeutics, Inc. $17.09 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141863353 Merck Sharp & Dohme LLC $14.72 07/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.